MedTrace Logo

Diagnosing Frontotemporal Lobar Degeneration

NCT02964637 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-03-30

No results posted yet for this study

Summary

To establish diagnostic tools to make an accurate clinical and pathological diagnosis of patients with clinical FTLD syndromes

Conditions

  • Corticobasal Syndrome
  • Progressive Supranuclear Palsy
  • Behavioral Variant Frontotemporal Dementia
  • Semantic Dementia
  • Progressive Nonfluent Aphasia
  • Amyotrophic Lateral Sclerosis And/or Frontotemporal Dementia

Interventions

OTHER

Observational Study

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Maria C Tartaglia, M.D. · Toronto Western Hospital, UHN; Tanz CRND

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02964637 on ClinicalTrials.gov